Coping with uncertainties: Monte Carlo simulation

SKIM has been using Monte Carlo simulation to help clients with forecasting the uptake of branded generics, biosimilars and targeted medicine – areas of increasing complexity and uncertainty. We gladly offer you a preview of our presentation at EphMRA's Annual Conference in Paris on June 21, 2012. Our experts Dirk Huisman and John Ashraf will talk about the principles of Monte Carlo Simulation and how it can be applied to forecast the uptake of your product.

Preview - Managing uncertainty in the forecast of the uptake of branded generics, biosimilars and targeted medicine

Ever-increasing complexity and uncertainty are a reality for the healthcare industry's commercial and strategy teams. In spite of these elements, however, decision makers must develop initiatives that help build a successful business. These strategic activities, which include commercialization plans and product launches, rely heavily on a plethora of data and business intelligence including, among many others, forecasts.

In the context of forecasting, 'increased complexity and more uncertainty' means that parameters used to build the forecast interact more; their accuracy is lower and not all conditions that may influence the forecast are known. Combined, these features result in an outcome that is impacted by an element of unpredictability.

In market research we are used to dealing with statistical uncertainty, but coping with data uncertainty (i.e., uncertain product profiles, uncertain access data, uncertain competitive actions, conflicting data sources, etc) calls for a different strategy. One approach is to use Monte Carlo simulation.

The basic principle of Monte Carlo simulation is to assign a random value, limited to an appropriate range, to each parameter. The full forecast is then generated using this random value and the process repeated thousands of times using different random numbers. It is crucial, therefore, to limit each parameter to the appropriate range and take into account the most likely value (i.e., the mean) and the probability of the other values within the range. This 'qualification' depends on other data sources (e.g., results of conjoint, insights from KOLs, desktop research, historical data, etc.) and is subjective.

In addition to the process of 'qualifying' the random values, it is essential to define action standards, essentially thresholds for taking action, at the outset. As these forecasts involve uncertainties, probabilities are attached to outcomes: for example, there is a 70% chance of reaching revenue of $500 million and a 90% chance of reaching $300 million. The associated action standard for this outcome is, for example, to in-license the product if the likelihood of revenue of $500 million is more than 80%. In this case, therefore, the decision would be a no-go. Action standards are based on the level of acceptable risk to make strategic choices such as a go/no go decision.

The challenges of Monte Carlo simulations are how to best and most accurately qualify parameters and decide on action standards at the outset of a research study. Both of these involve input from and a partnership between the market researchers and business intelligence managers.

Ultimately, Monte Carlo simulations are a way to obtain more accurate forecasts in areas of great complexity and uncertainty. As with a traditional forecast, however, the goal remains to deliver an estimate of market share and sales revenue.

SKIM is delighted to present our approach on managing uncertainty in forecasts at EphMRA 2012. Join Dirk Huisman and John Ashraf for their presentation on June 21, 2012 at 9:35 AM (Parallel Session 6) and/or meet the rest of the SKIM team at our booth on the agency fair!

About European Pharmaceutical Market Research Association (EphMRA)

The EphMRA annual conference of 2012, 'The 360 Future', focuses on looking at issues from all angles and possibilities, and examining the challenges we face in healthcare market research. The conference will take place on June 19-21, 2012 in Paris, France.

Want to know more? Don't hesitate to give us a call or drop an email!